Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$36.71 - $44.15 $1,615 - $1,942
-44 Reduced 0.47%
9,251 $384,000
Q1 2023

May 09, 2023

SELL
$36.81 - $48.12 $2.07 Million - $2.7 Million
-56,201 Reduced 85.81%
9,295 $383,000
Q4 2022

Feb 08, 2023

BUY
$35.68 - $44.71 $2.34 Million - $2.93 Million
65,496 New
65,496 $2.7 Million
Q1 2022

May 05, 2022

SELL
$48.09 - $57.79 $124,216 - $149,271
-2,583 Closed
0 $0
Q3 2021

Nov 08, 2021

SELL
$56.91 - $67.81 $62,430 - $74,387
-1,097 Reduced 29.81%
2,583 $154,000
Q1 2021

May 10, 2021

BUY
$53.26 - $68.08 $126,758 - $162,030
2,380 Added 183.08%
3,680 $241,000
Q4 2020

Feb 08, 2021

SELL
$43.41 - $56.51 $103,315 - $134,493
-2,380 Reduced 64.67%
1,300 $73,000
Q2 2020

Aug 05, 2020

SELL
$43.51 - $66.59 $31,979 - $48,943
-735 Reduced 16.65%
3,680 $204,000
Q1 2020

May 06, 2020

SELL
$32.82 - $81.13 $214,675 - $530,671
-6,541 Reduced 59.7%
4,415 $223,000
Q4 2019

Jan 29, 2020

BUY
$60.96 - $77.7 $467,075 - $595,337
7,662 Added 232.6%
10,956 $846,000
Q3 2019

Nov 01, 2019

BUY
$55.78 - $68.08 $183,739 - $224,255
3,294 New
3,294 $209,000
Q1 2019

May 13, 2019

SELL
$44.53 - $58.9 $62,698 - $82,931
-1,408 Closed
0 $0
Q3 2018

Oct 26, 2018

SELL
$52.03 - $71.41 $272,325 - $373,759
-5,234 Reduced 78.8%
1,408 $100,000
Q2 2018

Aug 08, 2018

BUY
$48.15 - $56.68 $71,021 - $83,603
1,475 Added 28.55%
6,642 $346,000
Q1 2018

May 11, 2018

BUY
$46.03 - $61.28 $34,982 - $46,572
760 Added 17.25%
5,167 $270,000
Q4 2017

Feb 06, 2018

SELL
$50.58 - $60.79 $639,482 - $768,567
-12,643 Reduced 74.15%
4,407 $261,000
Q3 2017

Nov 07, 2017

BUY
$53.54 - $68.0 $912,857 - $1.16 Million
17,050
17,050 $946,000

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.